IDR Middlefield REIT INDEXPLUS ETF

CALGARY, Feb. 19, 2019 /CNW/ - Middlefield Group is pleased to announce the launch of a Exchange-Traded Funds ("ETFs") platform that will provide investors with professional active management within a cost-effective, investor-friendly structure. The platform provides exposure to unique, actively managed strategies on a lower cost basis which investors may have difficulty replicating on their own or with passive investment products.   We are initially converting two successful closed-end funds, Middlefield Healthcare & Life Sciences Dividend Fund ("LS.UN") and REIT INDEXPLUS Income Fund ("IDR.UN"), as approved by unitholders at special meetings held on December 10, 2018.  A final prospectus dated February 12, 2019 has been filed with the securities regulatory authorities in each province and territory in Canada.

Commencing today, Middlefield Healthcare & Life Sciences ETF (new TSX ticker symbol: LS) and REIT INDEXPLUS ETF (new TSX ticker symbol: IDR) begin trading as ETFs. The conversions to ETFs were not taxable events for unitholders and units of the funds were converted to units of the applicable ETF on a 1:1 basis with all costs associated with the conversions being borne by the Manager. 

About Middlefield Group

Middlefield was established in 1979 and has approximately $4 billion in assets under management. Middlefield is a Specialty Investment Manager which creates investment products designed to balance risk and return to meet the demanding requirements of Financial Advisors and their clients. These financial products include Mutual Funds, ETFs, Private and Public Resource Funds, Venture Capital Assets, TSX Publicly Traded Funds and Real Estate Investment Funds and Partnerships.                                      

Certain statements in this press release may be viewed as forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, intentions, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects", "is expected", "anticipates", "plans", "estimates" or "intends" (or negative or grammatical variations thereof), or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements. There are no assurances the funds can fulfill such forward-looking statements and the funds do not undertake any obligation to update such statements. Such forward-looking statements are only predictions; actual events or results may differ materially as a result of risks facing one or more of the funds, many of which are beyond the control of the funds.

Commissions, trailing commissions, management fees and expenses all may be associated with ETFs. Please read the prospectus before investing. ETFs are not guaranteed, their values change frequently and past performance may not be repeated.

SOURCE Middlefield Healthcare & Life Sciences ETF